Upexi Approves Share Buyback Program Worth Up to $50 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 13 2025
0mins
Source: NASDAQ.COM
Stock Repurchase Authorization: Upexi, Inc. has announced authorization to repurchase up to $50 million of its common stock to enhance shareholder value.
Management's Perspective: CEO Allan Marshall stated that the repurchase program will be utilized when it represents an attractive return on capital without hindering strategic growth or treasury strength.
Market Activity: In pre-market trading, Upexi shares were priced at $3.41, reflecting a 1.17% increase on the Nasdaq.
Disclaimer: The views expressed in the article are those of the author and do not necessarily represent the opinions of Nasdaq, Inc.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like UPXI with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on UPXI
Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.960
Low
6.00
Averages
6.00
High
6.00
Current: 1.960
Low
6.00
Averages
6.00
High
6.00
About UPXI
Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Upexi Announces Q2 2026 Earnings Call Schedule
- Earnings Call Announcement: Upexi plans to host a conference call on February 10, 2026, to report its financial results for Q2 2026, which ended on December 31, 2025, likely drawing significant investor interest.
- Call Details: The call is scheduled for 5:30 p.m. ET, with participants able to dial in at 1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International), ensuring broad accessibility for stakeholders.
- Replay Availability: For those unable to join live, a replay of the call will be available until February 24, 2026, accessible by dialing 1-844-512-2921 (U.S. Toll-Free) or 1-412-317-6671 (International), providing continued access to the information shared.
- Company Overview: Upexi is a digital asset treasury company focused on acquiring and holding Solana (SOL) in a disciplined manner, utilizing mechanisms like intelligent capital issuance and staking, currently holding over two million SOL, positioning itself strategically in the market.
Continue Reading
Upexi to Participate in January 2026 Investor Conferences
- Investor Conference Schedule: Upexi will participate in the 12th Annual Alpha North Capital Event from January 16-18, 2026, at the Grand Hyatt Baha Mar in the Bahamas, with Chief Strategy Officer Brian Rudick attending to enhance investor engagement.
- Virtual Conference Participation: The company will also attend the Sidoti Micro-Cap Virtual Conference on January 21-22, 2026, where Brian Rudick will present on January 22 from 11:30 AM to 12:00 PM EST, further showcasing the company's strategic direction.
- Digital Asset Strategy: Upexi currently holds over 2 million Solana (SOL) and aims to increase its digital asset value through intelligent capital issuance, staking, and discounted locked token purchases, positioning itself prudently in various market environments.
- Brand Development: In addition to digital assets, Upexi focuses on the development, manufacturing, and distribution of consumer products, demonstrating its strategic diversification in business operations.
Continue Reading